期刊文献+

Non-alcoholic fatty liver disease: What the clinician needs to know 被引量:46

Non-alcoholic fatty liver disease: What the clinician needs to know
下载PDF
导出
摘要 Non-alcoholic fatty liver disease(NAFLD) is the most frequent cause of liver disease in the Western world. Furthermore, it is increasing worldwide, paralleling the obesity pandemic. Though highly frequent, only about one fifth of affected subjects are at risk of developing the progressive form of the disease, non-alcoholic steatohepatitis with fibrosis. Even in the latter, liver disease is slowly progressive, though, since it is so prevalent, it is already the third cause of liver transplantation in the United States, and it is predicted to get to the top of the ranking in few years. Of relevance, fatty liver is also associated with increased overall mortality and particularly increased cardiovascular mortality. The literature and amount of published papers on NAFLD is increasing as fast as its prevalence, which makes it difficult to keep updated in this topic. This review aims to summarize the latest knowledge on NAFLD, in order to help clinicians understanding its pathogenesis and advances on diagnosis and treatment. Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of liver disease in the Western world. Furthermore, it is increasing worldwide, paralleling the obesity pandemic. Though highly frequent, only about one fifth of affected subjects are at risk of developing the progressive form of the disease, non-alcoholic steatohepatitis with fibrosis. Even in the latter, liver disease is slowly progressive, though, since it is so prevalent, it is already the third cause of liver transplantation in the United States, and it is predicted to get to the top of the ranking in few years. Of relevance, fatty liver is also associated with increased overall mortality and particularly increased cardiovascular mortality. The literature and amount of published papers on NAFLD is increasing as fast as its prevalence, which makes it difficult to keep updated in this topic. This review aims to summarize the latest knowledge on NAFLD, in order to help clinicians understanding its pathogenesis and advances on diagnosis and treatment.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第36期12956-12980,共25页 世界胃肠病学杂志(英文版)
关键词 Non-alcoholic FATTY LIVER disease Metabolicsyndrom Non-alcoholic fatty liver disease Metabolic syndrome Insulin resistance Epidemiology Pathogenesis Genetics Diagnosis Prognosis Management
  • 相关文献

参考文献17

二级参考文献106

  • 1Ibolya Czegle,Miklós Csala,József Mandl,Angelo Benedetti,István Karádi,Gábor Bánhegyi.在肝的 G6PT-H6PDH-11HSD1 三个一组和它在新陈代谢的症候群的 pathomechanism 的含意[J].World Journal of Hepatology,2012,4(4):129-138. 被引量:2
  • 2[1]Neuschwander-Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology 2003; 37:1202-1219
  • 3[2]Szczepaniak LS,Nurenberg P,Leonard D,Browning JD,Reingold JS,Grundy S,Hobbs HH,Dobbins RL.Magnetic resonance spectroscopy to measure hepatic triglyceride content:prevalence of hepatic steatosis in the general population.Am J Physiol Endocrinol Metab 2005; 288:E462-E468
  • 4[3]Wanless IR,Lentz JS.Fatty liver hepatitis (steatohepatitis) and obesity:an autopsy study with analysis of risk factors.Hepatology 1990; 12:1106-1110
  • 5[4]Powell EE,Cooksley WG,Hanson R,Searle J,Halliday JW,Powell LW.The natural history of nonalcoholic steatohepatitis:a follow-up study of forty-two patients for up to 21 years.Hepatology 1990; 11:74-80
  • 6[5]Marchesini G,Bugianesi E,Forlani G,Cerrelli F,Lenzi M,Manini R,Natale S,Vanni E,Villanova N,Melchionda N,Rizzetto M.Nonalcoholic fatty liver,steatohepatitis,and the metabolic syndrome.Hepatology 2003; 37:917-923
  • 7[6]Bugianesi E,Marzocchi R,Villanova N,Marchesini G.Nonalcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH):treatment.Best Pract Res Clin Gastroenterol 2004;18:1105-1116
  • 8[7]Andersen T,Gluud C,Franzmann MB,Christoffersen P.Hepatic effects of dietary weight loss in morbidly obese subjects.J Hepatol 1991; 12:224-229
  • 9[8]Dixon JB,Bhathal PS,Hughes NR,O'Brien PE.Nonalcoholic fatty liver disease:Improvement in liver histological analysis with weight loss.Hepatology 2004; 39:1647-1654
  • 10[9]Luyckx FH,Desaive C,Thiry A,Dewe W,Scheen AJ,Gielen JE,Lefebvre PJ.Liver abnormalities in severely obese subjects:effect of drastic weight loss after gastroplasty.Int J Obes Relat Metab Disord 1998; 22:222-226

共引文献123

同被引文献537

引证文献46

二级引证文献235

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部